California-based, RapidAI is a health tech AI designed to prevent life-threatening vascular, cardiac, and neurovascular diseases that raised $75 million led by Vista Credit Partners in a Series C round.
Vista Equity Partners subsidiary Vista Credit Partners led the round independently.
RapidAI AI-Powered $75M Series By Vista Credit
CEO RapidAI, Karim Karti said that the funds raised enable us to add more diseases to our platform and make our product a good fit for the market.
RapidAI is an AI platform that has complete care for stroke diseases. RapidAI working on Rapid NCCT Stroke (an FDA-approved medical device that detects ICH and LVO).
Rapid NCCT Stroke has imaging capabilities that a hospital can use to address wider health issues. Moreover, RapidAI is working on additional programs to diagnose other diseases early.
Also Read: Sekoia.io Raised €35M Series A